Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
Electrical Impedance Spectroscopy for Characterization of Prostate PC-3 and DU 145 Cancer CellsViviane S Teixeira, Tobias Barth, Vera Labitzky, et al.
Plos One|August 8, 2013
E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft modelDaniel Wicklein, Anna Schmidt, Vera Labitzky, et al.
BMC Cancer|June 7, 2020
The initial engraftment of tumor cells is critical for the future growth pattern: a mathematical study based on simulations and animal experimentsBertin Hoffmann, Tobias Lange, Vera Labitzky, et al.
Molecular Oncology|June 1, 2021
Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancerYi Ding, Vera Labitzky, Karen Legler, et al.
Glycobiology|February 28, 2020
Systematic analysis of the human tumor cell binding to human vs. murine E- and P-selectin under static vs. dynamic conditionsSarah Starzonek, Hanna Maar, Vera Labitzky, et al.
Iscience|October 14, 2021
Site-specific <i>N</i>-glycosylation of integrin α2 mediates collagen-dependent cell survivalYen-Lin Huang, Ching-Yeu Liang, Vera Labitzky, et al.
Molecular Oncology|February 3, 2021
Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsetsTanja Spethmann, Lukas Clemens Böckelmann, Vera Labitzky, et al.
NPJ Precision Oncology|July 19, 2022
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancerOmar Elakad, Björn Häupl, Vera Labitzky, et al.
Cancers|February 13, 2020
Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in MiceVera Labitzky, Anke Baranowsky, Hanna Maar, et al.
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
Pageof 2